Direct Oral Anticoagulant stands for 'Direct Oral AntiCoagulant' and refers to a group of new anticoagulant medications.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Direct Oral Anticoagulant industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Apixaban
Dabigatran
Rivaroxaban
Edoxaban
Market Segment by Product Application
Hospitals Pharmacies
Drug Stores
Online Pharmacies
Finally, the report provides detailed profile and data information analysis of leading company.
Bristol-Meyers Squibb Co
Pfizer Inc.
Boehringer Ingelheim Pharmaceuticals, Inc
Janssen Pharmaceuticals, Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd
Pab Organics Private Limited
Daiichi Sankyo Company, Limited
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Direct Oral Anticoagulant consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Direct Oral Anticoagulant market by identifying its various subsegments.
3.Focuses on the key global Direct Oral Anticoagulant manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Direct Oral Anticoagulant with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Direct Oral Anticoagulant submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Direct Oral Anticoagulant Market Research Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Direct Oral Anticoagulant Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Direct Oral Anticoagulant Segment by Type
2.1.1 Apixaban
2.1.2 Dabigatran
2.1.3 Rivaroxaban
2.1.4 Edoxaban
2.2 Market Analysis by Application
2.2.1 Hospitals Pharmacies
2.2.2 Drug Stores
2.2.3 Online Pharmacies
2.3 Global Direct Oral Anticoagulant Market Comparison by Regions (2016-2026)
2.3.1 Global Direct Oral Anticoagulant Market Size (2016-2026)
2.3.2 North America Direct Oral Anticoagulant Status and Prospect (2016-2026)
2.3.3 Europe Direct Oral Anticoagulant Status and Prospect (2016-2026)
2.3.4 China Direct Oral Anticoagulant Status and Prospect (2016-2026)
2.3.5 Japan Direct Oral Anticoagulant Status and Prospect (2016-2026)
2.3.6 Southeast Asia Direct Oral Anticoagulant Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Direct Oral Anticoagulant Industry Impact
2.5.1 Direct Oral Anticoagulant Business Impact Assessment - Covid-19
2.5.2 Market Trends and Direct Oral Anticoagulant Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Direct Oral Anticoagulant Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Direct Oral Anticoagulant Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Direct Oral Anticoagulant Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Direct Oral Anticoagulant Manufacturer Market Share
3.5 Top 10 Direct Oral Anticoagulant Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Direct Oral Anticoagulant Market
3.7 Key Manufacturers Direct Oral Anticoagulant Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Direct Oral Anticoagulant Industry Key Manufacturers
4.1 Bristol-Meyers Squibb Co
4.1.1 Compan Detail
4.1.2 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product Introduction, Application and Specification
4.1.3 Bristol-Meyers Squibb Co 135 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Bristol-Meyers Squibb Co News
4.2 Pfizer Inc.
4.2.1 Compan Detail
4.2.2 Pfizer Inc. Direct Oral Anticoagulant Product Introduction, Application and Specification
4.2.3 Pfizer Inc. Direct Oral Anticoagulant Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Bristol-Meyers Squibb Co News
4.3 Boehringer Ingelheim Pharmaceuticals, Inc
4.3.1 Compan Detail
4.3.2 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product Introduction, Application and Specification
4.3.3 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Boehringer Ingelheim Pharmaceuticals, Inc News
4.4 Janssen Pharmaceuticals, Inc.
4.4.1 Compan Detail
4.4.2 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product Introduction, Application and Specification
4.4.3 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Janssen Pharmaceuticals, Inc. News
4.5 Bayer AG
4.5.1 Compan Detail
4.5.2 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product Introduction, Application and Specification
4.5.3 Bayer AG Direct Oral Anticoagulant Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Bayer AG News
4.6 Teva Pharmaceutical Industries Ltd
4.6.1 Compan Detail
4.6.2 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product Introduction, Application and Specification
4.6.3 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Teva Pharmaceutical Industries Ltd News
4.7 Pab Organics Private Limited
4.7.1 Compan Detail
4.7.2 Pab Organics Private Limited Direct Oral Anticoagulant Product Introduction, Application and Specification
4.7.3 Pab Organics Private Limited Direct Oral Anticoagulant Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Daiichi Sankyo Company, Limited
4.8.1 Compan Detail
4.8.2 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product Introduction, Application and Specification
4.8.3 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 Daiichi Sankyo Company, Limited News
5 Global Direct Oral Anticoagulant Market Segment by Big Type
5.1 Global Direct Oral Anticoagulant Revenue, Sales and Market Share by Big Type (2016-2021)
5.1.1 Global Direct Oral Anticoagulant Sales and Market Share by Big Type (2016-2021)
5.1.2 Global Direct Oral Anticoagulant Revenue and Market Share by Big Type (2016-2021)
5.2 Apixaban Sales Growth Rate and Price
5.2.1 Global Apixaban Sales Growth Rate (2016-2021)
5.2.2 Global Apixaban Price (2016-2021)
5.3 Dabigatran Sales Growth Rate and Price
5.3.1 Global Dabigatran Sales Growth Rate (2016-2021)
5.3.2 Global Dabigatran Price (2016-2021)
5.4 Rivaroxaban Sales Growth Rate and Price
5.4.1 Global Rivaroxaban Sales Growth Rate (2016-2021)
5.4.2 Global Rivaroxaban Price (2016-2021)
5.5 Edoxaban Sales Growth Rate and Price
5.5.1 Global Edoxaban Sales Growth Rate (2016-2021)
5.5.2 Global Edoxaban Price (2016-2021)
6 Global Direct Oral Anticoagulant Market Segment by Big Application
6.1 Global Direct Oral Anticoagulant Sales Market Share by Big Application (2016-2021)
6.2 Hospitals Pharmacies Sales Growth Rate (2016-2021)
6.3 Drug Stores Sales Growth Rate (2016-2021)
6.4 Online Pharmacies Sales Growth Rate (2016-2021)
7 Global Direct Oral Anticoagulant Forecast
7.1 Global Direct Oral Anticoagulant Revenue, Sales and Growth Rate (2021-2026)
7.2 Direct Oral Anticoagulant Market Forecast by Regions (2021-2026)
7.2.1 North America Direct Oral Anticoagulant Market Forecast (2021-2026)
7.2.2 Europe Direct Oral Anticoagulant Market Forecast (2021-2026)
7.2.3 China Direct Oral Anticoagulant Market Forecast (2021-2026)
7.2.4 Japan Direct Oral Anticoagulant Market Forecast (2021-2026)
7.2.5 Southeast Asia Direct Oral Anticoagulant Market Forecast (2021-2026)
7.2.6 Other Regions Direct Oral Anticoagulant Market Forecast (2021-2026)
7.3 Direct Oral Anticoagulant Market Forecast by Type (2021-2026)
7.3.1 Global Direct Oral Anticoagulant Sales Forecast by Type (2021-2026)
7.3.2 Global Direct Oral Anticoagulant Market Share Forecast by Type (2021-2026)
7.4 Direct Oral Anticoagulant Market Forecast by Application (2021-2026)
7.4.1 Global Direct Oral Anticoagulant Sales Forecast by Application (2021-2026)
7.4.2 Global Direct Oral Anticoagulant Market Share Forecast by Application (2021-2026)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Direct Oral Anticoagulant Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Direct Oral Anticoagulant Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Direct Oral Anticoagulant
Figure Market Concentration Ratio and Market Maturity Analysis of Direct Oral Anticoagulant
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Direct Oral Anticoagulant Market Size by Big Type
Figure Global Market Share of Direct Oral Anticoagulant by Big Type in 2020
Figure Apixaban Picture (2016-2021)
Figure Dabigatran Picture (2016-2021)
Figure Rivaroxaban Picture (2016-2021)
Global Direct Oral Anticoagulant Market Size by Big Application
Table Global Direct Oral Anticoagulant Market Size by Application
Figure Global Direct Oral Anticoagulant Market Share by Big Application in 2020
Figure Hospitals Pharmacies Picture
Figure Drug Stores Picture
Figure Online Pharmacies Picture
Table Global Direct Oral Anticoagulant Comparison by Regions (M USD) ?2016-2026?
Figure Global Direct Oral Anticoagulant Market Size (Million US$) (2016-2026)
Figure North America Direct Oral Anticoagulant Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Direct Oral Anticoagulant Revenue (Million US$) Growth Rate (2016-2026)
Figure China Direct Oral Anticoagulant Revenue (Million US$) Growth Rate (2016-2026)
Figure Japan Direct Oral Anticoagulant Revenue (Million US$) Growth Rate (2016-2026)
Figure Southeast Asia Direct Oral Anticoagulant Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Direct Oral Anticoagulant Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Direct Oral Anticoagulant Sales by Manufacturer (2016-2021)
Figure Global Direct Oral Anticoagulant Sales Market Share by Manufacturer in 2020
Table Global Direct Oral Anticoagulant Revenue by Manufacturer (2016-2021)
Figure Global Direct Oral Anticoagulant Revenue Market Share by Manufacturer in 2020
Table Global Direct Oral Anticoagulant Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Direct Oral Anticoagulant Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Direct Oral Anticoagulant Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Direct Oral Anticoagulant Market
Table Key Manufacturers Direct Oral Anticoagulant Product Type
Table Mergers & Acquisitions Planning
Table Bristol-Meyers Squibb Co Company Profile
Table Direct Oral Anticoagulant Product Introduction, Application and Specification of Bristol-Meyers Squibb Co
Table Direct Oral Anticoagulant Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021
Table Company One Main Business
Table Company One Recent Development
Table Pfizer Inc. Company Profile
Table Direct Oral Anticoagulant Product Introduction, Application and Specification of Pfizer Inc.
Table Direct Oral Anticoagulant Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Pfizer Inc. Recent Development
Table Boehringer Ingelheim Pharmaceuticals, Inc Company Profile
Table Direct Oral Anticoagulant Product Introduction, Application and Specification of Boehringer Ingelheim Pharmaceuticals, Inc
Table Direct Oral Anticoagulant Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Boehringer Ingelheim Pharmaceuticals, Inc Main Business
Table Boehringer Ingelheim Pharmaceuticals, Inc Recent Development
Table Janssen Pharmaceuticals, Inc. Company Profile
Table Direct Oral Anticoagulant Product Introduction, Application and Specification of Janssen Pharmaceuticals, Inc.
Table Direct Oral Anticoagulant Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Janssen Pharmaceuticals, Inc. Main Business
Table Janssen Pharmaceuticals, Inc. Recent Development
Table Janssen Pharmaceuticals, Inc. Main Business
Table Janssen Pharmaceuticals, Inc. Recent Development
Table Bayer AG Company Profile
Table Direct Oral Anticoagulant Product Introduction, Application and Specification of Bayer AG
Table Direct Oral Anticoagulant Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Bayer AG Main Business
Table Bayer AG Recent Development
Table Teva Pharmaceutical Industries Ltd Company Profile
Table Direct Oral Anticoagulant Product Introduction, Application and Specification of Teva Pharmaceutical Industries Ltd
Table Direct Oral Anticoagulant Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Teva Pharmaceutical Industries Ltd Main Business
Table Teva Pharmaceutical Industries Ltd Recent Development
Table Pab Organics Private Limited Company Profile
Table Direct Oral Anticoagulant Product Introduction, Application and Specification of Pab Organics Private Limited
Table Direct Oral Anticoagulant Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Pab Organics Private Limited Main Business
Table Pab Organics Private Limited Recent Development
Table Daiichi Sankyo Company, Limited Company Profile
Table Direct Oral Anticoagulant Product Introduction, Application and Specification of Daiichi Sankyo Company, Limited
Table Direct Oral Anticoagulant Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Daiichi Sankyo Company, Limited Main Business
Table Daiichi Sankyo Company, Limited Recent Development
Figure Global Direct Oral Anticoagulant Sales and Growth Rate (2016-2021)
Figure Global Direct Oral Anticoagulant Revenue and Growth Rate (2016-2021)
Table Global Direct Oral Anticoagulant Sales by Regions (2016-2021)
Figure Global Direct Oral Anticoagulant Sales Market Share by Regions in 2020
Table Global Direct Oral Anticoagulant Revenue by Regions (2016-2021)
Figure Global Direct Oral Anticoagulant Revenue Market Share by Regions in 2020
Figure North America Direct Oral Anticoagulant Sales and Growth Rate (2016-2021)
Figure Europe Direct Oral Anticoagulant Sales and Growth Rate (2016-2021)
Figure China Direct Oral Anticoagulant Sales and Growth Rate (2016-2021)
Figure Japan Direct Oral Anticoagulant Sales and Growth Rate (2016-2021)
Figure Southeast Asia Direct Oral Anticoagulant Sales and Growth Rate (2016-2021)
Figure Other Regions Direct Oral Anticoagulant Sales and Growth Rate (2016-2021)
Table Global Direct Oral Anticoagulant Sales by Big Type (2016-2021)
Table Global Direct Oral Anticoagulant Sales Market Share by Big Type (2016-2021)
Figure Global Direct Oral Anticoagulant Sales Market Share by Big Type in 2019
Table Global Direct Oral Anticoagulant Revenue by Big Type (2016-2021)
Table Global Direct Oral Anticoagulant Revenue Market Share by Big Type (2016-2021)
Table Global Direct Oral Anticoagulant Revenue Market Share by Big Type in 2019
Figure Global Apixaban Sales Growth Rate (2016-2021)
Figure Global Apixaban Price (2016-2021)
Figure Global Dabigatran Sales Growth Rate (2016-2021)
Figure Global Dabigatran Price (2016-2021)
Figure Global Rivaroxaban Sales Growth Rate (2016-2021)
Figure Global Rivaroxaban Price (2016-2021)
Figure Global Edoxaban Sales Growth Rate (2016-2021)
Table Global Direct Oral Anticoagulant Sales by Big Application (2016-2021)
Table Global Direct Oral Anticoagulant Sales Market Share by Big Application (2016-2021)
Figure Global Direct Oral Anticoagulant Sales Market Share by Big Application in 2019
Figure Global Hospitals Pharmacies Sales Growth Rate (2016-2021)
Figure Global Drug Stores Sales Growth Rate (2016-2021)
Figure Global Online Pharmacies Sales Growth Rate (2016-2021)
Figure Global Direct Oral Anticoagulant Sales and Growth Rate (2021-2026)
Figure Global Direct Oral Anticoagulant Revenue and Growth Rate (2021-2026)
Table Global Direct Oral Anticoagulant Sales Forecast by Regions (2021-2026)
Table Global Direct Oral Anticoagulant Market Share Forecast by Regions (2021-2026)
Figure North America Sales Direct Oral Anticoagulant Market Forecast (2021-2026)
Figure Europe Sales Direct Oral Anticoagulant Market Forecast (2021-2026)
Figure China Sales Direct Oral Anticoagulant Market Forecast (2021-2026)
Figure Japan Sales Direct Oral Anticoagulant Market Forecast (2021-2026)
Figure Southeast Asia Sales Direct Oral Anticoagulant Market Forecast (2021-2026)
Figure Other Regions Sales Direct Oral Anticoagulant Market Forecast (2021-2026)
Table Global Direct Oral Anticoagulant Sales Forecast by Type (2021-2026)
Table Global Direct Oral Anticoagulant Market Share Forecast by Type (2021-2026)
Table Global Direct Oral Anticoagulant Sales Forecast by Application (2021-2026)
Table Global Direct Oral Anticoagulant Market Share Forecast by Application (2021-2026)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Direct Oral Anticoagulant
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Direct Oral Anticoagulant Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Direct Oral Anticoagulant Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Direct Oral Anticoagulant Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Direct Oral Anticoagulant Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Direct Oral Anticoagulant Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Direct Oral Anticoagulant Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Direct Oral Anticoagulant Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Direct Oral Anticoagulant Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Bristol-Meyers Squibb Co
Pfizer Inc.
Boehringer Ingelheim Pharmaceuticals, Inc
Janssen Pharmaceuticals, Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd